The Leader in

Fc Effector Function

Characterization

SCIENTIFIC CASE STUDY

Comprehensive Antigen-Specific Characterization of Anti-CD20 mAbs

High-throughput immune

profiling for

antibody discovery

and development.

How broad, antigen-specific Fc profiling uncovered immune mechanisms that conventional characterization approaches can overlook.

Target: CD20

Assays performed

Therapeutic area: Oncology

Molecule type: Monoclonal antibodies

Looking Beyond Conventional Fc Characterization Reveals Hidden Mechanisms of Therapeutic Antibodies

The Project
Scientist in blue gloves examines a clear liquid in a flask under a microscope.

Comprehensive Support Across All Stages of Development

Customized Assay Design for Therapeutic Antibody Development

From early discovery to clinical development, our platform provides customizable solutions to support each phase of antibody development. Whether it’s mechanism of action analysis, functional profiling, or candidate optimization, we offer the insights needed to advance your projects.

Our platform supports a range of therapeutic modalities, with expertise in monoclonal antibody (mAb) characterization, bispecific antibody (bsAbs) characterization, Antibody Drug Conjugate (ADC) characterization, and more.

We used all forms of social media to meet the audience in their most comfortable locations, and talked in their own language.

Related Projects